Femme et Homme
- | Pays :
- France
- | Organes : -
- | Spécialités : -
Extrait
The objective of this study is to determine the feasibility of pazopanib treatment interruption with reintroduction at progression in iodine refractory progressive Differentiated Thyroid Cancer (DTC) patients as compared to pazopanib continuous administration.
Critère d'inclusion
- Thyroid carcinoma